English

Eligibility Prostate Cancer NCT00199537

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
men
Description

Gender

Data type

boolean

Alias
UMLS CUI [1]
C0079399
age of 40 years or greater
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
diagnosis of advanced prostate cancer (ie: prostate-specific antigen [psa] less than 25 ug/l and undergoing continued treatment with leuteinizing hormone-releasing hormone [lhrh] therapy)
Description

Prostate carcinoma Advanced | Prostate specific antigen measurement | LHRH

Data type

boolean

Alias
UMLS CUI [1,1]
C0600139
UMLS CUI [1,2]
C0205179
UMLS CUI [2]
C0201544
UMLS CUI [3]
C0023610
willing and able to consent
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
metastatic disease to bone
Description

Secondary malignant neoplasm of bone

Data type

boolean

Alias
UMLS CUI [1]
C0153690
medications affecting bone turnover (bisphosphonate, steroids, anticonvulsant)
Description

Pharmaceutical Preparations Affecting Bone remodeling | Diphosphonates | Steroids | Anticonvulsants

Data type

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C0085268
UMLS CUI [2]
C0012544
UMLS CUI [3]
C0038317
UMLS CUI [4]
C0003286
renal failure (serum creatinine > 200 umol/l)
Description

Kidney Failure | Creatinine measurement, serum

Data type

boolean

Alias
UMLS CUI [1]
C0035078
UMLS CUI [2]
C0201976
co-morbidity factors affecting bone density (ie: paget's, rheumatoid arthritis)
Description

Comorbidity Affecting Bone Density | Paget's Disease | Rheumatoid Arthritis

Data type

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C0005938
UMLS CUI [2]
C1368019
UMLS CUI [3]
C0003873
factors affecting ability to perform the bone density tests using femoral head measurements (ie: bilateral hip arthroplasty)
Description

Factor Affecting Bone Density Test | Head of femur Measurement | Arthroplasty of hip, bilateral

Data type

boolean

Alias
UMLS CUI [1,1]
C1521761
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C0177804
UMLS CUI [2,1]
C0015813
UMLS CUI [2,2]
C0242485
UMLS CUI [3]
C0845633
cancer other than skin, except when, in the investigators' opinion, it is determined to be appropriate and not adversely affect the outcome of the trial
Description

Malignant Neoplasms | Malignant Neoplasms Affecting research results

Data type

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C0006826
UMLS CUI [2,2]
C0392760
UMLS CUI [2,3]
C0683954
gastrointestinal (gi) pathology (eg. malabsorption syndrome)
Description

Gastrointestinal Diseases | Malabsorption Syndrome

Data type

boolean

Alias
UMLS CUI [1]
C0017178
UMLS CUI [2]
C0024523
parathyroid disease
Description

Parathyroid Diseases

Data type

boolean

Alias
UMLS CUI [1]
C0030517
Back to the top of the page

Similar models

Eligibility Prostate Cancer NCT00199537

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Gender
Item
men
boolean
C0079399 (UMLS CUI [1])
Age
Item
age of 40 years or greater
boolean
C0001779 (UMLS CUI [1])
Prostate carcinoma Advanced | Prostate specific antigen measurement | LHRH
Item
diagnosis of advanced prostate cancer (ie: prostate-specific antigen [psa] less than 25 ug/l and undergoing continued treatment with leuteinizing hormone-releasing hormone [lhrh] therapy)
boolean
C0600139 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C0201544 (UMLS CUI [2])
C0023610 (UMLS CUI [3])
Informed Consent
Item
willing and able to consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Secondary malignant neoplasm of bone
Item
metastatic disease to bone
boolean
C0153690 (UMLS CUI [1])
Pharmaceutical Preparations Affecting Bone remodeling | Diphosphonates | Steroids | Anticonvulsants
Item
medications affecting bone turnover (bisphosphonate, steroids, anticonvulsant)
boolean
C0013227 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0085268 (UMLS CUI [1,3])
C0012544 (UMLS CUI [2])
C0038317 (UMLS CUI [3])
C0003286 (UMLS CUI [4])
Kidney Failure | Creatinine measurement, serum
Item
renal failure (serum creatinine > 200 umol/l)
boolean
C0035078 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
Comorbidity Affecting Bone Density | Paget's Disease | Rheumatoid Arthritis
Item
co-morbidity factors affecting bone density (ie: paget's, rheumatoid arthritis)
boolean
C0009488 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0005938 (UMLS CUI [1,3])
C1368019 (UMLS CUI [2])
C0003873 (UMLS CUI [3])
Factor Affecting Bone Density Test | Head of femur Measurement | Arthroplasty of hip, bilateral
Item
factors affecting ability to perform the bone density tests using femoral head measurements (ie: bilateral hip arthroplasty)
boolean
C1521761 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0177804 (UMLS CUI [1,3])
C0015813 (UMLS CUI [2,1])
C0242485 (UMLS CUI [2,2])
C0845633 (UMLS CUI [3])
Malignant Neoplasms | Malignant Neoplasms Affecting research results
Item
cancer other than skin, except when, in the investigators' opinion, it is determined to be appropriate and not adversely affect the outcome of the trial
boolean
C0006826 (UMLS CUI [1])
C0006826 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C0683954 (UMLS CUI [2,3])
Gastrointestinal Diseases | Malabsorption Syndrome
Item
gastrointestinal (gi) pathology (eg. malabsorption syndrome)
boolean
C0017178 (UMLS CUI [1])
C0024523 (UMLS CUI [2])
Parathyroid Diseases
Item
parathyroid disease
boolean
C0030517 (UMLS CUI [1])
Back to the top of the page